Chelsea Mayoh
Children's Cancer Institute, NSW, Australia

Chelsea Mayoh is a principal bioinformatic scientist at the Children’s Cancer Institute, specialising in multi-omics data analysis and integration. Her research aims to uncover known and novel drivers of paediatric cancer by integrating genome, transcriptome, and methylome data. She focuses on developing personalised treatment recommendations to reduce side effects from standard chemotherapy, enhancing the diagnostic power of RNA -sequencing in precision medicine, and investigating the tumour immune microenvironment in childhood cancers.
Presentations this author is a contributor to:
Using copper chelation to target epigenetic and kinase signalling influence of cell cycle in DIPG (#39)
12:45 PM
Filip Michniewicz
Concurrent Session - Cancer Biology
Identification of drivers of resistance in BRAFV600E paediatric high-grade glioma and novel therapeutic targets (#129)
12:45 PM
Rebecca Lehmann
Lunch & Poster Viewing (Odd Numbers)
Developing combination therapies with the FACT-inhibitor CBL0137 for diffuse midline glioma (DMG) (#120)
1:00 PM
Holly Holliday
Lunch & Poster Viewing (Even Numbers)